Largest health care pharmaceutical companies by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 health care pharmaceutical companies ranked by total debt, at SEK 688B, ahead of Pfizer (SEK 660.5B) and Merck & Co (SEK 502.6B). Figures as of 20 Nov 2026, 02:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieSEK 688B
- Median
- SEK 53.8B
- Combined market value
- SEK 50.59T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 688B | SEK 5.11T | SEK 2,890.37 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | SEK 660.5B | SEK 1.6T | SEK 280.74 | 1.85% down | 15% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 502.6B | SEK 3.34T | SEK 1,353.85 | 3.61% down | 45% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | SEK 488.7B | SEK 6.56T | SEK 2,723.19 | 2.04% down | 34% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | SEK 459.9B | SEK 1.22T | SEK 594.71 | 2.05% down | 30% up | ||
| 6 | Eli LillyLLY · Health Care | SEK 433.3B | SEK 12.27T | SEK 13,773.14 | 2.29% down | 33% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SEK 311.7B | SEK 697.3B | SEK 218.25 | 0.66% up | 51% up | ||
| 8 | AstraZenecaAZN · Health Care | SEK 302B | SEK 2.77T | SEK 1,788.11 | 1.87% down | 1% up | ||
| 9 | NovartisNVS · Health Care | SEK 292.9B | SEK 2.91T | SEK 1,541.52 | 2.57% down | 25% up | ||
| 10 | SanofiSNY · Health Care | SEK 211.5B | SEK 1.13T | SEK 469.53 | 2.25% down | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | SEK 198.1B | SEK 1.75T | SEK 396.24 | 1.42% down | 17% down | ||
| 12 | GSKGSK · Health Care | SEK 195.6B | SEK 977.1B | SEK 487.47 | 1.56% down | 5% up | ||
| 13 | ViatrisVTRS · Health Care | SEK 146.9B | SEK 232.3B | SEK 202.65 | 1.97% down | 99% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | SEK 131.8B | SEK 1.83T | SEK 1,058.84 | 0.58% down | 16% down | ||
| 15 | ZoetisZTS · Health Care | SEK 92.2B | SEK 334.6B | SEK 823.56 | 5.59% down | 26% down | ||
| 16 | Royalty PharmaRPRX · Health Care | SEK 91.2B | SEK 396.9B | SEK 690.33 | 1.38% down | 79% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 54.6B | SEK 154.7B | SEK 2,410.34 | 4.57% down | 41% up | ||
| 18 | GenmabGMAB · Health Care | SEK 53.8B | SEK 322.8B | SEK 523.46 | 0.75% up | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SEK 40.9B | SEK 134B | SEK 268.00 | 1.54% down | 26% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | SEK 26.2B | SEK 76B | SEK 218.05 | 2.24% down | 90% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | SEK 20.5B | SEK 155.2B | SEK 796.96 | 0.22% up | 21% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | SEK 20.2B | SEK 973.7B | SEK 9,412.41 | 2.35% down | 28% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | SEK 18.5B | SEK 46.2B | SEK 277.48 | 0.62% down | 63% down | ||
| 24 | BeOne MedicinesONC · Health Care | SEK 10.5B | SEK 465.4B | SEK 4,074.49 | 0.97% down | 16% up | ||
| 25 | Ascendis PharmaASND · Health Care | SEK 8.1B | SEK 171.2B | SEK 2,609.22 | 5.32% down | 29% up | ||
| 26 | InsmedINSM · Health Care | SEK 5.6B | SEK 323.1B | SEK 1,472.61 | 20.58% up | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 3.5B | SEK 93.9B | SEK 4,044.32 | 0.34% down | 27% down | ||
| 28 | Legend BiotechLEGN · Health Care | SEK 3.3B | SEK 31.8B | SEK 164.12 | 0.92% down | 41% down | ||
| 29 | CytokineticsCYTK · Health Care | SEK 2.9B | SEK 73.1B | SEK 524.58 | 0.27% up | 19% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | SEK 2.5B | SEK 100B | SEK 661.38 | 1.88% down | 117% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | SEK 2.3B | SEK 49.2B | SEK 282.78 | 0.25% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 2B | SEK 126B | SEK 151.18 | 1.00% down | 8% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | SEK 1.9B | SEK 72.8B | SEK 1,383.10 | 1.25% up | 6% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.1B | SEK 82.5B | SEK 1,190.64 | 1.88% down | 18% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | SEK 413.7M | SEK 41.1B | SEK 300.52 | 1.24% up | 168% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1939 SEK). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by total debt?
AbbVie (SEK 688B), Pfizer (SEK 660.5B) and Merck & Co (SEK 502.6B) are the top three of the 35 health care pharmaceutical companies ranked by total debt as of 20 Nov 2026, 02:43 UTC.
How many health care pharmaceutical companies are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 35 health care pharmaceutical companies ranked by total debt have a combined market value of SEK 50.59T as of 20 Nov 2026, 02:43 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.